MIBG for Refractory Neuroblastoma and Pheochromocytoma

Clinical trial NCT01850888 · COMPLETED

Trial details

NCT number: NCT01850888
Sponsor: Masonic Cancer Center, University of Minnesota
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Relapsed Neuroblastoma Metastatic Pheochromocytoma

Start date: 2013-12-01
Primary completion: 2025-10-20
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.